» Articles » PMID: 34222055

Association Between Cardiometabolic Risk Factors and COVID-19 Susceptibility, Severity and Mortality: a Review

Overview
Specialty Endocrinology
Date 2021 Jul 5
PMID 34222055
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The novel coronavirus, which began spreading from China Wuhan and gradually spreaded to most countries, led to the announcement by the World Health Organization on March 11, 2020, as a new pandemic. The most important point presented by the World Health Organization about this disease is to better understand the risk factors that exacerbate the course of the disease and worsen its prognosis. Due to the high majority of cardio metabolic risk factors like obesity, hypertension, diabetes, and dyslipidemia among the population over 60 years old and higher, these cardio metabolic risk factors along with the age of these people could worsen the prognosis of the coronavirus disease of 2019 (COVID-19) and its mortality. In this study, we aimed to review the articles from the beginning of the pandemic on the impression of cardio metabolic risk factors on COVID-19 and the effectiveness of COVID-19 on how to manage these diseases. All the factors studied in this article, including hypertension, diabetes mellitus, dyslipidemia, and obesity exacerbate the course of Covid-19 disease by different mechanisms, and the inflammatory process caused by coronavirus can also create a vicious cycle in controlling these diseases for patients.

Citing Articles

Cardiovascular Symposium on Perspectives in Long COVID.

Dieter R, Kempaiah P, Dieter E, Alcazar A, Tafur A, Gerotziafas G Clin Appl Thromb Hemost. 2025; 31:10760296251319963.

PMID: 39943820 PMC: 11822813. DOI: 10.1177/10760296251319963.


Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients.

Gonzalez-Ochoa A, Szolnoky G, Hernandez-Ibarra A, Fareed J Clin Appl Thromb Hemost. 2025; 31():10760296241297647.

PMID: 39763448 PMC: 11705351. DOI: 10.1177/10760296241297647.


Individual risk factors associated with SARS-CoV-2 infection during Alpha variant in high-income countries: a systematic review and meta-analysis.

Moniz M, Pereira S, Soares P, Aguiar P, Donato H, Leite A Front Public Health. 2024; 12:1367480.

PMID: 39139667 PMC: 11319152. DOI: 10.3389/fpubh.2024.1367480.


Effect of COVID-19 on Type 2 Diabetes Self-Care Behaviors: A Rapid Review.

Olausson J, Brady V, Storey S Diabetes Spectr. 2023; 36(3):228-244.

PMID: 37583557 PMC: 10425230. DOI: 10.2337/ds22-0060.


Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients.

Cheung K, Lam L, Mao X, Tan J, Hwa Ooi P, Zhang R Vaccines (Basel). 2023; 11(3).

PMID: 36992081 PMC: 10054100. DOI: 10.3390/vaccines11030497.


References
1.
Mukherjee J, Gangopadhyay K, Ray S . Management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020; 8(8):666. PMC: 7373395. DOI: 10.1016/S2213-8587(20)30226-6. View

2.
Solaimanzadeh I . Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19. Cureus. 2020; 12(5):e8069. PMC: 7219014. DOI: 10.7759/cureus.8069. View

3.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

4.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

5.
Lebovitz H . Thiazolidinediones: the Forgotten Diabetes Medications. Curr Diab Rep. 2019; 19(12):151. PMC: 6881429. DOI: 10.1007/s11892-019-1270-y. View